In a report released today, Brian Quast from BMO Capital maintained a Buy rating on B2Gold, with a price target of C$7.50. The company’s shares opened today at $3.80. Take advantage of TipRanks ...

B2Gold nears major growth with the Goose Mine launch, sector-low valuation, and strong cash flow amid high gold prices. Find ...

Caledonia Mining is fairly valued after a 130% YTD rally, with most upside now priced in and Zimbabwe risk remaining.

Brazilian bank BTG Pactual has acquired the Uruguayan operations of British bank HSBC for US$175 million, marking BTG Pactual ...

Brazilian bank BTG Pactual announced on Monday it agreed to buy HSBC operations in Uruguay for $175 million, the former investment bank’s first foray into a Spanish-speaking nation. Under regulatory ...

MacRury covers the Basic Materials sector, focusing on stocks such as Alamos Gold, Franco-Nevada, and B2Gold. According to TipRanks, MacRury has an average return of 17.9% and a 65.98% success rate on ...

LONDON (Alliance News) - BTG PLC said Thursday it has entered into a second non-disclosure agreement with US medical manufacturing giant Boston Scientific Corp.

To bolster its offerings in interventional medicine, Boston Scientific agreed to purchase British device and pharma firm BTG PLC. for $4.24 billion in cash, according to The Wall Street Journal.

* ‍COURT OF CHANCERY OF DELAWARE HAS ISSUED ITS FINAL ORDER AND JUDGEMENT IN RELATION TO LITIGATION BETWEEN BTG AND WELLSTAT THERAPEUTICS Sign up here. * ‍CONFIRMS COURT'S RULING THAT BTG HAS ...